Tomás Alarcón, Josep Sardanyés, Antoni Guillamón, Javier A. Menéndez. Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs. PLoS Computational Biology, 17(6), 2021. [doi]
@article{AlarconSGM21,
title = {Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs},
author = {Tomás Alarcón and Josep Sardanyés and Antoni Guillamón and Javier A. Menéndez},
year = {2021},
doi = {10.1371/journal.pcbi.1008408},
url = {https://doi.org/10.1371/journal.pcbi.1008408},
researchr = {https://researchr.org/publication/AlarconSGM21},
cites = {0},
citedby = {0},
journal = {PLoS Computational Biology},
volume = {17},
number = {6},
}